Bizelesin
- CAS NO.:129655-21-6
- Empirical Formula: C43H36Cl2N8O5
- Molecular Weight: 815.7
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:09
What is Bizelesin?
The Uses of Bizelesin
As members of the cyclopropylpyrroloindole family, Adozelesin and Bizelesin cause genomic DNA lesions by alkylating DNA. Adozelesin induces single-strand DNA lesions, whereas Bizelesin induces both si ngle-strand lesions and double-strand DNA cross-links. liferation by different pathways (i.e., Adozelesin induced apoptosis, and Bizelesin induced senescence).
Properties of Bizelesin
| Density | 1.604±0.06 g/cm3(Predicted) |
| pka | 10.06±0.40(Predicted) |
| form | Solid |
| color | Off-white to yellow |
Safety information for Bizelesin
Computed Descriptors for Bizelesin
New Products
(E)-1-Ethoxyethene-2-boronic Acid Pinacol Ester 1,3-Diethyl-1,3-Diphenylurea 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2,4-dihydroxybenzaldehyde 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile 1,3-Di Iodo Benzene Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 3-Hydroxy-4-nitrobromobenzene 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate Thio AcetamideRelated products of tetrahydrofuran






You may like
-
MFCD22560726 98%View Details
MFCD22560726 -
3-Hydroxy-4-nitrobromobenzene 98%View Details
2768-84-0 -
4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 98%View Details
1234064-08-4. -
2-Ethyl-1,4-diaminobenzene 98%View Details
MFCD19203885 -
85-81-4 6-Methoxy-8-nitroquinoline 98%View Details
85-81-4 -
2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile 98%View Details -
Hot Sales:Thio AcetamideView Details
62-55-5 -
CosmoticsView Details
26218-04-2
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
